drug
Efudex
Marketedupdated 5mo agoby Extrovis AG
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- tagApproval132 co-mentions · 66 sources
- drugFAVLYXA73 co-mentions · 72 sources
- drugFLUOROURACIL72 co-mentions · 72 sources
- drugRNS-6012 co-mentions · 12 sources
- companyFresenius Kabi USA LLC12 co-mentions · 12 sources
- tagOncology5 co-mentions · 2 sources
- drugFOLFOX [leucovorin + fluorouracil + oxaliplatin]1 co-mentions · 1 sources
- drugOXALIPLATIN1 co-mentions · 1 sources
all catalysts(42)
approval · 40
Sep 30, 1998
approval
FLUOROURACIL — FDA approval
Efudex
→
Sep 30, 1998
approval
FLUOROURACIL — FDA approval
Efudex
→
Jul 6, 1999
approval
FLUOROURACIL — FDA approval
Efudex
→
Jul 6, 1999
approval
FLUOROURACIL — FDA approval
Efudex
→
Dec 5, 2002
approval
FLUOROURACIL — FDA approval
Efudex
→
Dec 5, 2002
approval
FLUOROURACIL — FDA approval
Efudex
→
Apr 26, 2007
approval
FLUOROURACIL — FDA approval
Efudex
→
Apr 26, 2007
approval
FLUOROURACIL — FDA approval
Efudex
→
Feb 17, 2016
approval
FLUOROURACIL — FDA approval
Efudex
→
Nov 14, 2016
approval
FLUOROURACIL — FDA approval
Efudex
→
Dec 27, 2016
approval
FLUOROURACIL — FDA approval
Efudex
→
Dec 27, 2016
approval
FLUOROURACIL — FDA approval
Efudex
→
Jan 6, 2017
approval
FLUOROURACIL — FDA approval
Efudex
→
Jan 6, 2017
approval
FLUOROURACIL — FDA approval
Efudex
→
May 11, 2017
approval
FLUOROURACIL — FDA approval
Efudex
→
Oct 27, 2017
approval
FLUOROURACIL — FDA approval
Efudex
→
Dec 26, 2017
approval
FLUOROURACIL — FDA approval
Efudex
→
Sep 14, 2022
approval
FLUOROURACIL — FDA approval
Efudex
→
Sep 14, 2022
approval
FLUOROURACIL — FDA approval
Efudex
→
Mar 3, 2023
approval
FLUOROURACIL — FDA approval
Efudex
→
Oct 18, 2023
approval
FLUOROURACIL — FDA approval
Efudex
→
Mar 21, 2024
approval
FLUOROURACIL — FDA approval
Efudex
→
Mar 21, 2024
approval
FLUOROURACIL — FDA approval
Efudex
→
Mar 21, 2024
approval
FLUOROURACIL — FDA approval
Efudex
→
Mar 21, 2024
approval
FLUOROURACIL — FDA approval
Efudex
→
Mar 21, 2024
approval
FLUOROURACIL — FDA approval
Efudex
→
Mar 21, 2024
approval
FLUOROURACIL — FDA approval
Efudex
→
Mar 21, 2024
approval
FLUOROURACIL — FDA approval
Efudex
→
Mar 21, 2024
approval
FLUOROURACIL — FDA approval
Efudex
→
Mar 21, 2024
approval
FLUOROURACIL — FDA approval
Efudex
→
Mar 21, 2024
approval
FLUOROURACIL — FDA approval
Efudex
→
Feb 5, 2026
approval
FLUOROURACIL — FDA approval
Efudex
→
Feb 5, 2026
approval
FLUOROURACIL — FDA approval
Efudex
→
Feb 5, 2026
approval
FLUOROURACIL — FDA approval
Efudex
→
Feb 5, 2026
approval
FLUOROURACIL — FDA approval
Efudex
→
Feb 5, 2026
approval
FLUOROURACIL — FDA approval
Efudex
→
Feb 5, 2026
approval
FLUOROURACIL — FDA approval
Efudex
→
Feb 5, 2026
approval
FLUOROURACIL — FDA approval
Efudex
→
Feb 5, 2026
approval
FLUOROURACIL — FDA approval
Efudex
→
Feb 20, 2026
approval
FAVLYXA (FLUOROURACIL) — FDA approval
Efudex
→
phase 1 initiation · 1
Trials studying Efudex
- phase2A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
- phase2Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
- phase2AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
- phase1A Study of ASP3082 in Adults With Advanced Solid Tumors
- phase3Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)
- phase2A Study Investigating Alternate Schedules of Tislelizumab Plus Chemotherapy in Japanese Patients With First-line Advanced ESCC
- phase3A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- phase2Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
News(1)
- Dr Cohen on Frontline Chemotherapy Selection in Metastatic Pancreatic CancerDeirdre J. Cohen, MD, MS, discusses clinical decision-making and the comparative efficacy of FOLFIRINOX and NALIRIFOX in metastatic pancreatic cancer.onclive · 5mo ago
Data sources
last refreshed 44m ago
Found something off?
comments(0)
5-min edit window · permanent after that